Purdue University researchers secure $100,000 to advance cancer treatment and freshwater management technologies supported by the Trask Innovation Fund.
Distinguished Professor Andrew Mesecar leads a project targeting USP7 enzyme for hepatocellular carcinoma treatment with unique inhibitors to reduce off-target effects.
College of Engineering's Pablo Zavattieri heads a project developing a reconfigurable waterway barrier to combat saltwater intrusion in the Panama Canal.
Trask Innovation Fund aids in refining molecules for cancer therapy and testing a prototype barrier design for waterway intrusion prevention.
Purdue Innovates Incubator supports researchers in bridging academic innovation with marketable products to accelerate translation of discoveries.
Purdue's initiatives in biomedical science and environmental engineering demonstrate novel approaches to complex global challenges with intellectual property protection.
Mesecar's USP7 inhibitors offer precision in cancer treatment, while Zavattieri's waterway barrier enhances canal sustainability.
The projects showcase practical applications of university research driving solutions for health and environmental issues with commercialization pathways.
Academic innovation funds like Trask and incubators play a crucial role in advancing transformative technologies and shaping the future of science and technology.
Investments in early-stage innovations highlight Purdue's commitment to addressing critical global challenges through interdisciplinary research and collaboration.